Robotic Partial Nephrectomy with Indocyanine Green Fluorescence Navigation.
Lukas Gadus1,2, Jiri Kocarek3, Frantisek Chmelik1
1Department of Urology, Military University Hospital, Prague 16902, Czech Republic.
Contrast Media & Molecular Imaging
|May 16, 2020
Summary
Indocyanine green (ICG) fluorescence imaging aids robotic partial nephrectomy by enabling precise clamping of tumor vessels. This technique helps preserve kidney function and achieve good oncological outcomes in localized renal tumors.
Area of Science:
- Urology
- Surgical Oncology
- Medical Imaging
Background:
- Partial nephrectomy (PN) is a standard treatment for localized renal tumors.
- Intraoperative imaging, like indocyanine green (ICG) fluorescence, can enhance PN outcomes.
- Robotic PN offers minimally invasive advantages for kidney tumor removal.
Purpose of the Study:
- To evaluate the efficacy of robotic partial nephrectomy using indocyanine green (ICG) fluorescence imaging.
- To assess the impact of ICG navigation on surgical precision and renal function preservation.
- To determine the safety and oncological outcomes of ICG-enhanced robotic PN.
Main Methods:
- Retrospective analysis of 37 patients undergoing robotic PN with ICG fluorescence imaging between April 2015 and May 2019.
- Intravenous administration of 5 mg ICG for real-time fluorescent imaging during surgery.
- ICG use guided by tumor complexity (R.E.N.A.L. nephrometry score, unfavorable anatomy).
- Focus on superselective clamping of tumor-supplying renal artery branches.
Main Results:
- ICG facilitated precise detection of tissue perfusion borders and superselective arterial clamping in 25 cases.
- Mean surgery time was 133 minutes, with a mean estimated blood loss of 190 mL.
- Mean warm ischemia time was 14 minutes; favorable renal function was observed with superselective clamping.
- Low complication rates (2 Grade II, 1 Grade III Clavien-Dindo).
Conclusions:
- Indocyanine green (ICG) fluorescence imaging is a valuable tool for robotic partial nephrectomy.
- ICG enhances the ability to perform superselective clamping of tumor vessels, preserving renal function.
- Robotic PN with ICG navigation demonstrates acceptable oncological results and a favorable safety profile.


